CPI and the University of Strathclyde, in strategic partnership with GSK and AstraZeneca, today announced a new platform that will enable oral solid dosage medicines to be formulated more robustly and efficiently.

The advent of personalised medicine promises more efficacious treatments. However, moving away from a ‘one size fits all’ model demands new, adaptable and complex manufacturing processes for the next generation of therapeutics.

An array of industry experts, equipment suppliers, government and academia came together recently in Glasgow for a two-day, Road Mapping Workshop for the new Medicines Manufacturing Innovation Centre

This year CPI is celebrating its 15th Birthday. We were established in 2004 as a way to build on the existing capabilities in the North East and ensure the region remained competitive in the global marketplace. Since then CPI has grown exponentially and has now delivered over 1700 public and private R&D projects with a value of around £500m.

Following the launch of CPI’s new National Healthcare Photonics Centre, Tom Harvey, Healthcare Photonics Lead at CPI, looks at the facility’s long-term potential to support the medical technology (medtech) and healthcare markets.

Our entire economy is driven by consumption and disposal. This is fine – provided we use resources with the utmost efficiency and recover, reuse, remanufacture or recycle the valuable materials in our waste streams.